Tech Company Financing Transactions

Totus Medicines Funding Round

DCVC Bio, Camford Capital and Northpond Ventures participated in a $66 million Series B funding round for Totus Medicines. This VC investment round was announced on 12/15/2023.

Transaction Overview

Company Name
Announced On
12/15/2023
Transaction Type
Venture Equity
Amount
$66,000,000
Round
Series B
Proceeds Purpose
The Series B financing will be used to advance Totus' clinical program, expand the pipeline, and evolve the platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
700 Main St.
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Founded in 2019, Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Totus is based in Cambridge, Massachusetts.
Profile
Totus Medicines LinkedIn Company Profile
Social Media
Totus Medicines Company Twitter Account
Company News
Totus Medicines News
Facebook
Totus Medicines on Facebook
YouTube
Totus Medicines on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Neil Dhawan
  Neil Dhawan LinkedIn Profile  Neil Dhawan Twitter Account  Neil Dhawan News  Neil Dhawan on Facebook
Chief Financial Officer
Samuel Singer
  Samuel Singer LinkedIn Profile  Samuel Singer Twitter Account  Samuel Singer News  Samuel Singer on Facebook
Vice President
John MacDougall
  John MacDougall LinkedIn Profile  John MacDougall Twitter Account  John MacDougall News  John MacDougall on Facebook
VP - Administration
Jenna Stein
  Jenna Stein LinkedIn Profile  Jenna Stein Twitter Account  Jenna Stein News  Jenna Stein on Facebook
VP - Engineering
Ryan Tarver
  Ryan Tarver LinkedIn Profile  Ryan Tarver Twitter Account  Ryan Tarver News  Ryan Tarver on Facebook
VP - Human Resources
Daisy Chhokar
  Daisy Chhokar LinkedIn Profile  Daisy Chhokar Twitter Account  Daisy Chhokar News  Daisy Chhokar on Facebook
VP - Operations
Erika Whyte
  Erika Whyte LinkedIn Profile  Erika Whyte Twitter Account  Erika Whyte News  Erika Whyte on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/14/2023: FineCell venture capital transaction
Next: 12/15/2023: Spotta venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary